Nanosonics Limited (NAN) is involved in the manufacturing and distribution of the trophon EPR ultrasound probe disinfector and its associated consumables and accessories. It is also involved in research, development and commercialization of infection control and decontamination products and related technologies.
Nanosonics limited has a strong balance sheet, with positive cashflow and net cash. It has a strong technological niche and is a growing asset for healthcare services looking to manage infection prevention practices. While it doesn't pay a dividend, it is investing in the distribution of the trophon ultrasound probe disinfector and its associated consumables and accessories.
Current Products and related technologies
Developed and commercialised a unique automated disinfection technology, trophon®, representing the first major innovation in high level disinfection for ultrasound probes in more than 20 years.
The company also sells the associated infection prevention and control consumables for use in the machine. Products are sold to hospitals to help manage the spread to infections in Australia and overseas markets including North America, UK and Europe.
Want to see other interesting ASX Healthcare Shares stocks?
Would you like to invest in NAN?
Get access to all our research on NAN + our current best stocks to buy now. 14 days free. No credit card required just enter your email and you're away.
START YOUR 14 DAY FREE TRIAL
No restrictions, no limits.
Get access to all of Under the Radar Report data FREE for 14 days.
NO CREDIT CARD REQUIRED
JOIN UNDER THE RADAR REPORT
Simply provide your details below to get started.